Two Sigma Securities’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-3,085
| Closed | -$342K | – | 1675 |
|
|
2025
Q3 | $342K | Buy |
+3,085
| New | +$351K | 0.05% | 518 |
|
|
2025
Q1 | – | Sell |
-2,253
| Closed | -$208K | – | 1727 |
|
|
2024
Q4 | $208K | Buy |
+2,253
| New | +$203K | 0.03% | 962 |
|
|
2024
Q2 | – | Sell |
-26,567
| Closed | -$1.77M | – | 3220 |
|
|
2024
Q1 | $1.95M | Buy |
+26,567
| New | +$2.04M | 0.02% | 768 |
|
|
2023
Q4 | – | Sell |
-38,267
| Closed | -$2.98M | – | 3227 |
|
|
2023
Q3 | $2.87M | Buy |
+38,267
| New | +$2.94M | 0.03% | 538 |
|
|
2023
Q1 | – | Sell |
-4,283
| Closed | -$355K | – | 2881 |
|
|
2022
Q4 | $368K | Sell |
4,283
-18,881
| -82% | -$1.5M | 0.01% | 1349 |
|
|
2022
Q3 | $1.43M | Buy |
23,164
+16,221
| +234% | +$1.02M | 0.04% | 483 |
|
|
2022
Q2 | $429K | Buy |
+6,943
| New | +$430K | 0.02% | 1019 |
|
|
2021
Q3 | – | Sell |
-12,525
| Closed | -$880K | – | 1684 |
|
|
2021
Q2 | $862K | Buy |
+12,525
| New | +$836K | 0.03% | 449 |
|
|
2020
Q3 | – | Sell |
-3,363
| Closed | -$233K | – | 1425 |
|
|
2020
Q2 | $259K | Sell |
3,363
-7,858
| -70% | -$602K | 0.01% | 988 |
|
|
2020
Q1 | $839K | Buy |
11,221
+1,368
| +14% | +$94.5K | 0.02% | 437 |
|
|
2019
Q4 | $640K | Buy |
+9,853
| New | +$642K | ﹤0.01% | 1301 |
|
|
2019
Q3 | – | Sell |
-8,554
| Closed | -$559K | – | 2186 |
|
|
2019
Q2 | $578K | Sell |
8,554
-4,804
| -36% | -$316K | 0.01% | 1024 |
|
|
2019
Q1 | $868K | Buy |
13,358
+2,569
| +24% | +$171K | 0.01% | 606 |
|
|
2018
Q4 | $675K | Sell |
10,789
-18,786
| -64% | -$1.31M | 0.01% | 833 |
|
|
2018
Q3 | $2.28M | Sell |
29,575
-25
| -0.1% | -$1.89K | 0.01% | 648 |
|
|
2018
Q2 | $2.1M | Sell |
29,600
-22,340
| -43% | -$1.58M | 0.01% | 899 |
|
|
2018
Q1 | $3.92M | Buy |
51,940
+6,297
| +14% | +$501K | 0.02% | 569 |
|
|
2017
Q4 | $3.27M | Buy |
+45,643
| New | +$3.47M | 0.09% | 173 |
|
|
2017
Q3 | – | Sell |
-22,360
| Closed | -$1.58M | – | 1023 |
|
|
2017
Q2 | $1.58M | Sell |
22,360
-568
| -2% | -$37.8K | 0.3% | 51 |
|
|
2017
Q1 | $1.56M | Buy |
22,928
+9,230
| +67% | +$649K | 0.31% | 53 |
|
|
2016
Q4 | $981K | Buy |
13,698
+9,298
| +211% | +$691K | 0.33% | 56 |
|
|
2016
Q3 | $348K | Buy |
+4,400
| New | +$357K | 0.12% | 255 |
|
|
2016
Q1 | – | Sell |
-7,840
| Closed | -$793K | – | 333 |
|
|
2015
Q4 | $793K | Buy |
7,840
+3,767
| +92% | +$392K | 0.95% | 17 |
|
|
2015
Q3 | $400K | Sell |
4,073
-1,539
| -27% | -$171K | 0.63% | 43 |
|
|
2015
Q2 | $657K | Buy |
+5,612
| New | +$613K | 1.1% | 14 |
|
Other funds holding GILD
Two Sigma Securities's GILD Position: Q4 2025 in Review
Two Sigma Securities sold out of Gilead Sciences (GILD) in Q4 2025, closing a stake of 3,085 shares — an estimated $342K sold.
Two Sigma Securities first reported a position in GILD in Q2 2015 and held it in 25 quarters. The position peaked at $3.92M in Q1 2018. 2,222 funds tracked by Wall St. Rank hold GILD as of Q4 2025.
- Two Sigma Securities reported no remaining Gilead Sciences position as of Q4 2025 after selling out during the quarter.
- Two Sigma Securities sold 3,085 Gilead Sciences shares in Q4 2025, an estimated $342K.
- Two Sigma Securities first reported a position in Gilead Sciences in Q2 2015 and held it in 25 quarters.
- Two Sigma Securities's Gilead Sciences position peaked at $3.92M in Q1 2018.
- 2,222 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.
Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.